For a certain anticancer agent it was found a good cytotoxic action at 24 hr, even better at 48 hr, but a significant reduction in cytotoxicity at 72 hr when analysed on a cell line with MTT assay. Could it be something with the half life of the agent? if so how could you administer in vivo.